Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for allegedly being involved in a fraudulent stock promotion scheme that misled investors [2][4]. Group 1: Allegations - The lawsuit claims that Picard Medical failed to disclose that it was the subject of a fraudulent stock promotion scheme involving misinformation on social media and impersonated financial professionals [2]. - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [2]. Group 2: Stock Price Impact - On October 24, 2025, Picard's stock price experienced a significant crash of 70%, dropping to $3.99 per share [3]. - Following the crash, the company's share price has continued to decline, reaching approximately $2.00 per share [3]. Group 3: Class Action Participation - Shareholders interested in participating as lead plaintiffs in the class action must file their papers with the court by April 3, 2026 [4]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4].

Core Viewpoint - A class action has been filed against Charming Medical, Limited (NASDAQ: MCTA) for allegedly engaging in a fraudulent stock promotion scheme that misled investors and artificially inflated its stock price [1][2][3] Allegations - The complaint alleges that Charming Medical failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [2] - Insiders and/or affiliates reportedly used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2] - The company's public statements and risk disclosures did not mention the false rumors and artificial trading activity that were driving the stock price [2] Stock Price Surge - In the weeks leading up to November 12, 2025, Charming's share price increased from the initial public offering price of $4.00 to a peak of $29.36 per share, despite a lack of fundamental news justifying such a rise [3] - Investigations revealed that the stock was subject to an illicit promotion scheme that created a buying frenzy among retail investors through sensational but unfounded claims made by impersonators posing as legitimate financial advisors [3] - Trading of Charming's stock was halted by the SEC on November 12, 2025, and remains suspended due to the company's failure to provide required information to regulators [3] Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit papers to the court by February 17, 2026, and do not need to participate in the case to be eligible for recovery [4] - Absent class members can choose not to take action while still being eligible for potential recovery [4] Legal Representation - All representation in the class action is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]

Core Viewpoint - Jayud Global Logistics Limited is facing a class action lawsuit due to allegations of engaging in a fraudulent stock promotion scheme that misled investors during the class period from April 21, 2023, to April 30, 2025 [2]. Group 1: Allegations and Company Actions - The lawsuit claims that Jayud failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [3]. - Insiders allegedly used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign, which was not disclosed in Jayud's public statements [3]. - The company's share price reportedly surged from approximately $1.00 to an all-time high of around $8.00 per share without any fundamental news to justify this increase, indicating potential manipulation [4]. Group 2: Investor Information - Shareholders may be eligible to participate in the class action against Jayud, with a deadline for filing as lead plaintiff set for January 20, 2026 [5]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [5].